Publications
-
Palomer FX, Álvarez-Guardia D, Davidson MM, Chan TO, Feldman AM and Vazquez M.
The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells.
PLoS One . 6(5): . Number of citations: 29
-
Barroso E, Rodríguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer FX and Vazquez M.
The PPARß/d activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1a-Lipin 1-PPARa pathway leading to increased fatty acid oxidation.
Endocrinology . 152(5): 1848-1859. Number of citations: 128
-
Barroso E, Eyre E, Palomer FX and Vazquez M.
The peroxisome proliferator-activated receptor ß/d (PPARß/d) agonist GW501516 prevents TNF-a-induced NF-?B activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
BIOCHEMICAL PHARMACOLOGY . 81(4): 534-543. Number of citations: 63
-
Alvarez-Guardia D, Palomer FX, Coll T, Serrano L, Rodríguez-Calvo R, Davidson MM, Merlos M, El Kochairi I, Michalik L, Wahli W and Vazquez M.
PPARß/d activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1811(2): 59-67. Number of citations: 65
-
Alvarez-Guardia D, Palomer FX, Coll T, Davidson MM, Chan TO, Feldman AM, Laguna JC and Vazquez M.
The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells.
CARDIOVASCULAR RESEARCH . 87(3): 449-458. Number of citations: 157
-
Coll T, Barroso E, Alvarez-Guardia D, Serrano L, Salvadó L, Merlos M, Palomer FX and Vazquez M.
The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.
PPAR Research . 2010: . Number of citations: 22
-
Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer FX, Laguna JC and Vazquez M.
Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Endocrinology . 151(4): 1560-1569. Number of citations: 74
-
Coll T, Palomer FX, Blanco-Vaca F, Escolà-Gil JC, Sánchez RM, Laguna JC and Vazquez M.
Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.
Endocrinology . 151(2): 537-548. Number of citations: 54
-
Palomer FX, Alvarez-Guardia D, Rodríguez-Calvo R, Coll T, Laguna JC, Davidson MM, Chan TO, Feldman AM and Vazquez M.
TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.
CARDIOVASCULAR RESEARCH . 81(4): 703-712. Number of citations: 144
-
Rodríguez-Calvo R, Barroso E, Serrano L, Coll T, Sánchez RM, Merlos M, Palomer FX, Laguna JC and Vazquez M.
Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A.
HEPATOLOGY . 49(1): 106-115. Number of citations: 57